Article: Australian Agency Recommends Approval of First Biotech Product for Orthopaedic Medicine; Curis Comments On Report From Licensee.

Article: Curis' OP-1 Receives HDE Status in the United ...
Business Wire;  October 18, 2001 ;     700+ words ... ... Exemption (HDE) status for Curis' regenerative product OP-1. The approved indication ... is presently marketing OP-1 in Australia and the European Union, and will pay Curis royalties from sales in ... territories. Under the HDE, OP-1 Implant will be made ...

Article: CURIS, STRYKER GAIN LONG-AWAITED APPROVAL OF OP- 1 ...
BIOWORLD Today;  October 22, 2001 ;     700+ words ... ... intends to launch Curis' OP-1 later this quarter ... Platika, chairman of Curis, gave Stryker the credit for maneuvering OP-1 through the FDA ... fresh fractures. Curis has the rights in ... and, Platika said, OP-1 appears to be ...

Article: Curis Reports OP-1 Receives Marketing Clearance in ...
Business Wire;  May 17, 2001 ;     700+ words ... ... sustained product revenue stream for Curis," stated Doros Platika, M ... and chief executive officer of Curis. "OP-1 also represents one of the ... associated with malignancies." OP-1, under license by Curis to Stryker for orthopaedic and ...

Article: FDA DENIES CURIS, STRYKER PMA ON OP-1 FRACTURE ...
BIOWORLD Today;  January 31, 2001 ;     700+ words ...Curis Inc. and OP-1 implant partner ... treatment of autograft. Curis' stock fell 47 percent on the news. The OP-1 implant for treatment ... according to Curis. Curis' vice president of ... from the FDA concerning OP-1 doesn't change ...

Article: Curis Reports OP-1 Approved for Marketing in ...
Business Wire;  May 4, 2001 ;     700+ words ... ... commercially launch the OP-1 Implant in Australia ... congratulate the scientists at Curis and Stryker who have worked ... s strategy by making Curis one of the few biotechnology ... from product revenues." OP-1, under license by Curis to Stryker for orthopaedic ...

Article: OP-1 PMA Receives Not-Approvable Letter From FDA; ...
Business Wire;  January 30, 2001 ;     700+ words ... ... HealthWire)--Jan. 30, 2001 Curis, Inc. (NASDAQ:CRIS ... Market Approval (PMA) for OP-1 Implant(TM) for ... marketing authorization for OP-1 as a drug in the European ... later this quarter. OP-1 is under license by Curis to Stryker Corporation ...

Article: First Biotech Product for Orthopaedic Medicine Recommended for ...
Business Wire;  January 3, 2001 ;     700+ words ... ... Proprietary Medicinal Products (CPMP). OP-1, under license by Curis to Stryker Corporation for orthopaedic and ... president and chief executive officer of Curis. "OP-1 is based on Curis' expertise in key developmental biology pathways ...